The Effect of Concomitant Treatment with Aspirin and Famotidine on Platelet Function in Humans
Investigator: Granada, Juan
Phone Number: (713) 383-3575
24 Month, Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy and Safety Comparing Two Exposures of Concentration-Controlled
Certican With Reduced Neoral Versus 3.0g MMF With Standard Dose Neoral In De Novo Heart Transplant Recipients
Investigator: Guillermo, Torre-Amione
Phone Number: (713) 441-3575
A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects with Acute Coronary Syndromes who are to be Managed with Percutaneous
Coronary Intervention (CHAMPION-PCI)
Investigator: Kleiman, Neal
Phone Number: (713) 441-3910
A multi-center dose-ranging study of the REG1 Anticoagulation System to determine the pharmacokinetics, pharmacodynamics,
safety profile, and biochemical marker relationships in subjects with stable coronary artery disease on oral antiplatelet
therapy
Investigator: Kleiman, Neal
Phone Number: (713) 441-3910
Protocol H7T-MC-TABM A Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopigrel in Subjects with Acute Coronary
Syndrome Who Have Recently Undergone Percutaneous Coronary Intervention and Are Receiving Clopigerl (S.W.A.P. - Switching
Anti Plate
Investigator: Kleiman, Neal
Phone Number: (713) 441-3910
The Effect of Caffeine on the Response to Clopidogrel in Stable Patients with Coronary Artery Disease
Investigator: Kleiman, Neal
Phone Number: (713) 383-3910
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Exploratory Efficacy Study of Sitaxsentan Sodium to Improve Impaired
Exercise Tolerance in Subjects with Diastolic Heart Failure
Investigator: Kurrelmeyer, Karla
Phone Number: (713) 441-3575
Development of a Normal Database and Criteria for Abnormality for Beta-methyl-p-[123I]-Iodophenyl-pentadecanoic acid (Iodofiltic
acid I-123) for Quantitative Imaging
Investigator: Mahmarian, John
Phone Number: (713) 441-2849
Resyncronization Reverses Remodelnig in Systolic Left Ventricular Dysfunction (REVERSE)
Investigator: Nasir, Nadim
Phone Number: (713) 791-1978
RETHINQ (Resynchronization Therapy in Narrow QRS)
Investigator: Nasir, Nadim
Phone Number: 713) 791-1978
TRENDS Study
Investigator: Nasir, Nadim
Phone Number: (713) 791-1978
Victory IDE Clinical Study
Investigator: Nasir, Nadim
Phone Number: (713) 791-1978
A Multicenter, Non-Randomized Study of the 2.25 mm Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment
of Patients with the DeNovo Coronary Artery Lesions Sirus 2.25 MM Protocol P03-6320 Amend. 3 Dated January 8, 2004 - The Sirius
2.25
Investigator: Raizner, Albert
Phone Number: (713) 441-4123
Future Revascualrization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease- The Freedom
Trial
Investigator: Raizner, Albert
Phone Number: (713) 441-4123
Rhythm ID Going Head-to-Head Trial
Investigator: Rami, Tapan
Phone Number: (713) 383-5161
The role of contractile dysfunction in post heart transplant rejection
Investigator: Torre-Amione, Guillermo
Phone Number: (713) 383-3575
Evaluation of the ZilverR PTX-TM Vascular Stent in the Above-the-Knee Femoropopliteal Artery
Investigator: Walton, Brian
Phone Number: (713) 441-4123
